Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
44.56 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 222.503 | 286.326 | 28.003 | 31.34 | 142.086 | 139.952 | 51.963 |
| Short Term Investments
| 57.812 | 0 | 123.716 | 125.201 | 89.734 | 104.69 | 0 |
| Cash and Short Term Investments
| 280.315 | 286.326 | 251.719 | 156.541 | 231.82 | 139.952 | 51.963 |
| Net Receivables
| 78.286 | 67.968 | 23.994 | 3.267 | 0 | 0 | 0 |
| Inventory
| 22.403 | 22.312 | 5.565 | 1.513 | 0 | 0 | 0 |
| Other Current Assets
| 11.784 | 10.935 | 8.947 | 10.542 | 9.06 | 5.406 | 0.024 |
| Total Current Assets
| 392.788 | 387.541 | 190.225 | 166.592 | 236.35 | 119.363 | 51.975 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 9.814 | 1.99 | 2.345 | 2.55 | 3.242 | 3.733 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 249.819 | 252.925 | 58.954 | 18.74 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 249.819 | 252.925 | 58.954 | 18.74 | 0 | 0 | 0 |
| Long Term Investments
| 12.526 | 0 | 100 | 4.983 | 0 | 23.292 | 0 |
| Tax Assets
| 0 | 0 | -100 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 5.807 | 4.165 | 101.382 | 101.786 | 1.272 | 0.324 | 0 |
| Total Non-Current Assets
| 277.966 | 259.08 | 162.681 | 128.059 | 4.514 | 27.349 | 0 |
| Total Assets
| 670.754 | 646.621 | 352.906 | 294.651 | 240.864 | 146.712 | 51.975 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 14.618 | 7.416 | 8.69 | 9.166 | 3.151 | 3.351 | 0.269 |
| Short Term Debt
| 1.709 | 1.104 | 1.862 | 1.422 | 1.272 | 0.794 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 30.723 | 13.411 | 0 | 0 |
| Other Current Liabilities
| 110.224 | 78.544 | 54.177 | 32.008 | 14.039 | 8.931 | 2.18 |
| Total Current Liabilities
| 126.551 | 87.064 | 64.729 | 42.596 | 18.462 | 13.076 | 2.449 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 316.054 | 307.038 | 2.514 | 3.806 | 5.254 | 6.502 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 140.351 | 129.923 | 47.651 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -140.351 | -129.923 | -47.651 | 0 | 0 |
| Other Non-Current Liabilities
| 2.509 | 3.849 | 143.626 | 128.037 | 45.053 | -3.215 | 59.849 |
| Total Non-Current Liabilities
| 318.563 | 310.887 | 146.14 | 131.843 | 50.307 | 3.287 | 59.849 |
| Total Liabilities
| 445.114 | 397.951 | 210.869 | 174.439 | 68.769 | 16.363 | 62.298 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 146.712 | 66.839 |
| Common Stock
| 0.005 | 0.005 | 0.004 | 0.003 | 0.003 | 0.002 | 6.991 |
| Retained Earnings
| -644.181 | -556.239 | -392.824 | -257.159 | -173.171 | -69.901 | -17.348 |
| Accumulated Other Comprehensive Income/Loss
| -0.373 | 1.644 | -0.217 | -0.035 | 0.083 | 0.129 | -66.839 |
| Other Total Stockholders Equity
| 870.189 | 803.26 | 535.074 | 377.403 | 345.18 | 53.407 | 133.678 |
| Total Shareholders Equity
| 225.64 | 248.67 | -392.824 | 120.212 | -173.171 | -69.901 | -10.323 |
| Total Equity
| 225.64 | 248.67 | -392.824 | 120.212 | -173.171 | -69.901 | -10.323 |
| Total Liabilities & Shareholders Equity
| 670.754 | 646.621 | -181.955 | 294.651 | -104.402 | -53.538 | 51.975 |